Fibroblast inward-rectifier potassium current upregulation in profibrillatory atrial Remodeling

Circulation Research

Volumn 116, Issue 5, 2015, Pages 836-845

  Qi, Xiao Yan ^a   Huang, Hai ^a   Ordog, Balazs ^a   Luo, Xiaobin ^a   Naud, Patrice ^a   Sun, Yiguo ^a   Wu, Chia Tung ^a,c   Dawson, Kristin ^a,b   Tadevosyan, Artavazd ^a   Chen, Yu ^a,b   Harada, Masahide ^a,d   Dobrev, Dobromir ^e   Nattel, Stanley ^a,c  

^a MONTREAL HEART INSTITUTE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

Author keywords

Arrhythmias; Cardiac

Indexed keywords

INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; MESSENGER RNA; MICRORNA 26A; CALCIUM; HYBRID PROTEIN; INWARDLY RECTIFYING POTASSIUM CHANNEL; MICRORNA; POTASSIUM;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; FIBROBLAST; HEART ATRIUM REMODELING; HYPERPOLARIZATION; MALE; MEMBRANE STEADY POTENTIAL; MONGREL DOG; NONHUMAN; PATCH CLAMP TECHNIQUE; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; ATRIAL FIBRILLATION; CELL CYCLE; CELL DIVISION; COMPLICATION; DOG; FIBROSIS; GENE EXPRESSION REGULATION; GENETIC TRANSDUCTION; GENETICS; HEART FAILURE; HEART PACING; ION TRANSPORT; MEMBRANE POTENTIAL; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REPORTER GENE;

ANIMALS; ATRIAL FIBRILLATION; ATRIAL REMODELING; CALCIUM; CARDIAC PACING, ARTIFICIAL; CELL CYCLE; CELL DIVISION; DOGS; FEMALE; FIBROBLASTS; FIBROSIS; GENE EXPRESSION REGULATION; GENES, REPORTER; HEART FAILURE; ION TRANSPORT; MALE; MEMBRANE POTENTIALS; MICRORNAS; PATCH-CLAMP TECHNIQUES; POTASSIUM; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RECOMBINANT FUSION PROTEINS; TRANSDUCTION, GENETIC; UP-REGULATION;

EID: 84924573864     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.116.305326     Document Type: Article

References (29)

1. Andrade J, Khairy P, Dobrev D, Nattel S. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ Res. 2014;114:1453-1468. doi: 10.1161/CIRCRESAHA.114.303211.
2. Li D, Fareh S, Leung TK, Nattel S. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation. 1999;100:87-95.
3. Yue L, Xie J, Nattel S. Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation. Cardiovasc Res. 2011;89:744-753. doi: 10.1093/cvr/cvq329.
4. Kamkin A, Kiseleva I, Isenberg G. Activation and inactivation of a nonselective cation conductance by local mechanical deformation of acutely isolated cardiac fibroblasts. Cardiovasc Res. 2003;57:793-803.
5. + currents regulate the resting membrane potential, proliferation, and contractile responses in ventricular fibroblasts and myofibroblasts. Am J Physiol Heart Circ Physiol. 2005;288:H2931-H2939. doi: 10.1152/ajpheart.01220.2004.
6. Wu CT, Qi XY, Huang H, Naud P, Dawson K, Yeh YH, Harada M, Kuo CT, Nattel S. Disease and region-related cardiac fibroblast potassium current variations and potential functional significance. Cardiovasc Res. 2014;102:487-496. doi: 10.1093/cvr/cvu055.
7. Dawson K, Wu CT, Qi XY, Nattel S. Congestive heart failure effects on atrial fibroblast phenotype: differences between freshly-isolated and cultured cells. PLoS One. 2012;7:e52032. doi: 10.1371/journal.pone.0052032.
8. Harada M, Luo X, Qi XY, et al. Transient receptor potential canonical-3 channel-dependent fibroblast regulation in atrial fibrillation. Circulation. 2012;126:2051-2064. doi: 10.1161/CIRCULATIONAHA.112.121830.
9. Thomas J, Epshtein Y, Chopra A, Ordog B, Ghassemi M, Christman JW, Nattel S, Cook JL, Levitan I. Anthrax lethal factor activates K(+) channels to induce IL-1β secretion in macrophages. J Immunol. 2011;186:5236-5243. doi: 10.4049/jimmunol.1001078.
10. Dawson K, Wakili R, Ordog B, Clauss S, Chen Y, Iwasaki Y, Voigt N, Qi XY, Sinner MF, Dobrev D, Kaab S, Nattel S. MicroRNA29: a mechanistic contributor and potential biomarker in atrial fibrillation. Circulation. 2013;127:1466-1475. doi: 10.1161/CIRCULATIONAHA.112.001207.
11. Yamazaki J, Sato K, Ohara F, Nagao T. Direct activation of endothelial NO pathway by Ba2+ in canine coronary artery. Br J Pharmacol. 1998;124:1149-1158. doi: 10.1038/sj.bjp.0701948.
12. Luo X, Pan Z, Shan H, et al. MicroRNA-26 governs profibrillatory in-ward-rectifier potassium current changes in atrial fibrillation. J Clin Invest. 2013;123:1939-1951. doi: 10.1172/JCI62185.
13. 2+ signals confer fibrogenesis in human atrial fibrillation. Circ Res. 2010;106:992-1003. doi: 10.1161/CIRCRESAHA.109.206771.
14. Zlochiver S, Muñoz V, Vikstrom KL, Taffet SM, Berenfeld O, Jalife J. Electrotonic myofibroblast-to-myocyte coupling increases propensity to reentrant arrhythmias in two-dimensional cardiac monolayers. Biophys J. 2008;95:4469-4480. doi: 10.1529/biophysj.108.136473.
15. Rohr S. Arrhythmogenic implications of fibroblast-myocyte interactions. Circ Arrhythm Electrophysiol. 2012;5:442-452. doi: 10.1161/CIRCEP.110.957647.
16. Ashihara T, Haraguchi R, Nakazawa K, Namba T, Ikeda T, Nakazawa Y, Ozawa T, Ito M, Horie M, Trayanova NA. The role of fibroblasts in complex fractionated electrograms during persistent/permanent atrial fibrillation: implications for electrogram-based catheter ablation. Circ Res.2012;110:275-284. doi: 10.1161/CIRCRESAHA.111.255026.
17. Aguilar M, Qi XY, Huang H, Comtois P, Nattel S. Fibroblast electrical remodeling in heart failure and potential effects on atrial fibrillation. Biophys J. 2014;107:2444-2455. doi: 10.1016/j.bpj.2014.10.014.
18. + pump activity modulate resting and bradykinin-stimulated changes in cytosolic free calcium in cultured endothelial cells from bovine atria. J Biol Chem. 1990;265:2613-2619.
19. + current. Arterioscler Thromb Vasc Biol. 2004;24:1229-1233. doi: 10.1161/01.ATV.0000130663.37663.6a.
20. Dora KA, Garland CJ. Linking hyperpolarization to endothelial cell calcium events in arterioles. Microcirculation. 2013;20:248-256. doi: 10.1111/micc.12041.
21. Burstein B, Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol. 2008;51:802-809. doi: 10.1016/j.jacc.2007.09.064.
22. Souders CA, Bowers SL, Baudino TA. Cardiac fibroblast: the renaissance cell. Circ Res. 2009;105:1164-1176. doi: 10.1161/CIRCRESAHA.109.209809.
23. Nattel S, Carlsson L. Innovative approaches to anti-arrhythmic drug therapy. Nat Rev Drug Discov. 2006;5:1034-1049. doi: 10.1038/nrd2112.
24. Zaritsky JJ, Redell JB, Tempel BL, Schwarz TL. The consequences of disrupting cardiac inwardly rectifying K(+) current (I(K1)) as revealed by the targeted deletion of the murine Kir2.1 and Kir2.2 genes. J Physiol. 2001;533:697-710.
25. K1 inhibition by a new pentamidine analogue. Cardiovasc Res. 2013;99:203-214. doi: 10.1093/cvr/cvt103.
26. Filgueiras-Rama D, Martins RP, Mironov S, Yamazaki M, Calvo CJ, Ennis SR, Bandaru K, Noujaim SF, Kalifa J, Berenfeld O, Jalife J. Chloroquine terminates stretch-induced atrial fibrillation more effectively than flecainide in the sheep heart. Circ Arrhythm Electrophysiol. 2012;5:561-570. doi: 10.1161/CIRCEP.111.966820.
27. Pandit SV, Berenfeld O, Anumonwo JM, Zaritski RM, Kneller J, Nattel S, Jalife J. Ionic determinants of functional reentry in a 2-D model of human atrial cells during simulated chronic atrial fibrillation. Biophys J. 2005;88:3806-3821. doi: 10.1529/biophysj.105.060459.
28. Hou L, Hu B, Jalife J. Genetically engineered excitable cardiac myofibroblasts coupled to cardiomyocytes rescue normal propagation and reduce arrhythmia complexity in heterocellular monolayers. PLoS One. 2013;8:e55400. doi: 10.1371/journal.pone.0055400.
29. Kumarswamy R, Thum T. Non-coding RNAs in cardiac remodeling and heart failure. Circ Res. 2013;113:676-689. doi: 10.1161/CIRCRESAHA.113.300226.